153 related articles for article (PubMed ID: 29375007)
1. Recognition mechanism of Wilms' tumour suppressor protein and DNA triplets: insights from molecular dynamics simulation and free energy analysis.
Zhang LF; Zheng QC; Zhang HX
J Biomol Struct Dyn; 2019 Feb; 37(3):562-575. PubMed ID: 29375007
[TBL] [Abstract][Full Text] [Related]
2. RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.
Nishikawa T; Wojciak JM; Dyson HJ; Wright PE
Biochemistry; 2020 Oct; 59(40):3889-3901. PubMed ID: 32955251
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
Laity JH; Chung J; Dyson HJ; Wright PE
Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
[TBL] [Abstract][Full Text] [Related]
4. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
[TBL] [Abstract][Full Text] [Related]
5. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.
Laity JH; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11932-5. PubMed ID: 11050227
[TBL] [Abstract][Full Text] [Related]
7. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
[TBL] [Abstract][Full Text] [Related]
8. Structure of the Wilms tumor suppressor protein zinc finger domain bound to DNA.
Stoll R; Lee BM; Debler EW; Laity JH; Wilson IA; Dyson HJ; Wright PE
J Mol Biol; 2007 Oct; 372(5):1227-45. PubMed ID: 17716689
[TBL] [Abstract][Full Text] [Related]
9. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
Ullmark T; Montano G; Gullberg U
Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258
[TBL] [Abstract][Full Text] [Related]
10. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
Zhai G; Iskandar M; Barilla K; Romaniuk PJ
Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
[TBL] [Abstract][Full Text] [Related]
11. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
Hamilton TB; Barilla KC; Romaniuk PJ
Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
[TBL] [Abstract][Full Text] [Related]
12. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
[TBL] [Abstract][Full Text] [Related]
13. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
[TBL] [Abstract][Full Text] [Related]
14. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
[TBL] [Abstract][Full Text] [Related]
15. Contribution of individual amino acids to the RNA binding activity of the Wilms' tumor suppressor protein WT1.
Weiss TC; Romaniuk PJ
Biochemistry; 2009 Jan; 48(1):148-55. PubMed ID: 19123921
[TBL] [Abstract][Full Text] [Related]
16. Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.
Hashimoto H; Zhang X; Zheng Y; Wilson GG; Cheng X
Nucleic Acids Res; 2016 Dec; 44(21):10165-10176. PubMed ID: 27596598
[TBL] [Abstract][Full Text] [Related]
17. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
[TBL] [Abstract][Full Text] [Related]
18. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
19. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study.
Nurmemmedov E; Yengo RK; Uysal H; Karlsson R; Thunnissen MM
Biophys Chem; 2009 Dec; 145(2-3):116-25. PubMed ID: 19853363
[TBL] [Abstract][Full Text] [Related]
20. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
